您当前所在的位置:首页 > 产品中心 > 产品详细信息
378-44-9 分子结构
点击图片或这里关闭

(1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one

ChemBase编号:326
分子式:C22H29FO5
平均质量:392.4610632
单一同位素质量:392.19990225
SMILES和InChIs

SMILES:
F[C@@]12[C@H]([C@H]3[C@@]([C@](O)([C@H](C3)C)C(=O)CO)(C[C@@H]1O)C)CCC1=CC(=O)C=C[C@]21C
Canonical SMILES:
OCC(=O)[C@@]1(O)[C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)F
InChI:
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1
InChIKey:
UREBDLICKHMUKA-DVTGEIKXSA-N

引用这个纪录

CBID:326 http://www.chembase.cn/molecule-326.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
(1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
(1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0?,?.0??,??]heptadeca-3,6-dien-5-one
(1R,2S,10S,11S,13S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
IUPAC传统名
betamethasone
商标名
Alphatrex
Bebate
Becort
Bedifos
Beta-Methasone
Beta-Methasone Alcohol
Beta-Val
Betacorlan
Betacortril
Betaderm
Betadexamethasone
Betafluorene
Betamamallet
Betametasona [INN-Spanish]
Betametasone [DCIT]
Betamethasone Alcohol
Betamethasone Base
Betamethasone Cream
Betamethasone Dipropionate
Betamethasone Sodium Phosphate
Betamethasone Valearate
Betamethasone Valerate
Betamethasone [Usan:Ban:Inn:Jan]
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betatrex
Betnelan
Betsolan
Celestene
Celestone
Celestone Syrup and Tablets
Cidoten
Dermabet
Desacort-Beta
Diproderm
Diprolene
Diprolene AF
Diprosone
Flubenisolone
Hormezon
Lotrisone
Luxiq
Luxiqo
Maxivate
Methazon
Rinderon
Rinderon A
Uticort
Valisone
Valnac
Visubeta
别名
9α-氟-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯-3,20-二酮
9α-氟-16β-甲基-11β,17α,21-三羟基-1,4-孕甾二烯-3,20-二酮
9α-氟-16β-甲基泼尼松龙
倍他米松
Betamethasone
(11β,16β)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
Sch-4831
NCS-39470
9α-Fluoro-16 β-methyl-prednisolone
9α-Fluoro-16 β-methyl-11β,17α, 21-trihydroxy-1,4-pregnadiene-3,20-dione
1,4-Pregnadiene-3,20-dione-9α-fluoro-16 β-methyl-11β,17α,21-triol
Betamethasone
Betamethasone valerate impurity A (PhEur)
9α-Fluoro-11β,17α,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione
9α-Fluoro-16β-methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione
9α-Fluoro-16β-methylprednisolone
Celestone
Betadexamethasone
Flubenisolone
Betamethasone (Celestone)
CAS号
378-44-9
EC号
206-825-4
MDL号
MFCD00062969
PubChem SID
46505155
24860978
160963789
24892150
24278276
PubChem CID
9782
CHEBI ID
3077
ATC码
H02AB01
S01CB04
D07AC01
R03BA04
S03BA03
S02BA07
C05AA05
A07EA04
S01BA06
R01AD06
CHEMBL
632
Chemspider ID
9399
DrugBank ID
DB00443
KEGG ID
D00244
美国药典/FDA物质标识码
9842X06Q6M
维基百科标题
Betamethasone

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 12.423736  质子受体
质子供体 LogD (pH = 5.5) 1.6815696 
LogD (pH = 7.4) 1.6815655  Log P 1.6815697 
摩尔折射率 102.4929 cm3 极化性 39.61867 Å3
极化表面积 94.83 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 1.93  LOG S -3.89 
溶解度 5.05e-02 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
Acetone expand 查看数据来源
DMSO expand 查看数据来源
Insoluble expand 查看数据来源
Methanol expand 查看数据来源
外观
White to Off-White Solid expand 查看数据来源
熔点
234-236°C expand 查看数据来源
235-237 °C(lit.) expand 查看数据来源
比旋光度
[α]20/D +105°, c = 1 in acetone expand 查看数据来源
疏水性(logP)
1.1 expand 查看数据来源
保存条件
-20°C expand 查看数据来源
-20°C Freezer expand 查看数据来源
Room Temperature (15-30°C) expand 查看数据来源
RTECS编号
TU4000000 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand 查看数据来源
保存温度
2-8°C expand 查看数据来源
给药途径
oral or topical expand 查看数据来源
排泄
Renal (in urine) expand 查看数据来源
半衰期
36-54 hours expand 查看数据来源
代谢
hepatic CYP3A4 expand 查看数据来源
法定药品分级
Rx-only expand 查看数据来源
妊娠期药物分类
C (US) expand 查看数据来源
相关基因信息
human ... ABCB1(5243), CYP3A4(1576), IL4(3565), IL5(3567), NR3C1(2908)mouse ... Abcb1a(18671), Abcb1b(18669), Ifng(15978), Nos2(18126), Tnf(21926)rat ... Ar(24208), Nr3c1(24413), Tnf(24835) expand 查看数据来源
纯度
≥95.0% (HPLC) expand 查看数据来源
≥98% expand 查看数据来源
98% expand 查看数据来源
级别
VETRANAL™, analytical standard expand 查看数据来源
成盐信息
Free Base expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
适用性
meets USP testing specifications expand 查看数据来源
简要说明
free compound expand 查看数据来源
杂质
≤10.0% related substances expand 查看数据来源
有效期
(limited shelf life, expiry date on the label) expand 查看数据来源
干燥失重
≤5.0% loss on drying expand 查看数据来源
Empirical Formula (Hill Notation)
C22H29FO5 expand 查看数据来源

详细说明

详细说明

MP Biomedicals MP Biomedicals DrugBank DrugBank Selleck Chemicals Selleck Chemicals Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich TRC TRC
MP Biomedicals -  02154853 external link
(9α-Fluoro-16β-methyl-prednisolone; 9α-Fluoro-16β-methyl-11β,17α, 21-trihydroxy-1,4-pregnadiene-3,20-dione; 1,4-Pregnadiene-3,20-dione-9α-fluoro-16β-methyl-11<
DrugBank -  DB00443 external link
Item Information
Drug Groups approved
Description A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Indication Topical use (cream, lotion and ointment): for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
Topical use (foam): relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp
Systemic use: for the treatment of edocrine disorders, rheumatic disorders, collagen diseases, dermatological diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, tuberculous meningitis and trichinosis.
Pharmacology Betamethasone and its derivatives, betamethasone sodium phosphate and betamethasone acetate, are synthetic glucocorticoids. Used for its antiinflammatory or immunosuppressive properties, betamethasone is combined with a mineralocorticoid to manage adrenal insufficiency and is used in the form of betamethasone benzoate, betamethasone dipropionate, or betamethasone valerate for the treatment of inflammation due to corticosteroid-responsive dermatoses. Betamethasone and clotrimazole are used together to treat cutaneous tinea infections.
Toxicity Symptoms of overdose include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Minimal if applied topically.
Half Life 5.6 hours
Protein Binding 64%
External Links
Wikipedia
RxList
Drugs.com
Selleck Chemicals -  S1500 external link
Research Area: Immunology
Biological Activity:
Betamethasone is a moderately potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.Betamethasone is a corticosteroid used as a topical cream to relieve skin irritation, such as itching and flaking from eczema. Betamethasone dipropionate and salicylic acid can be used as a treatment for local psoriasis. [1]
Sigma Aldrich -  B7005 external link
包装
100, 500 mg in poly bottle
Sigma Aldrich -  34166 external link
法律信息
VETRANAL 商标 Sigma-Aldrich Co. LLC
Toronto Research Chemicals -  B327000 external link
Betamethasone is a glucocorticoid used as an anti-inflammatory agent.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • http://en.wikipedia.org/wiki/Betamethasone
  • Ferrante, M.G., et al.: Anal. Profiles Drug Subs., 6, 43 (1977)
  • Li, A., et al.: Chem. Biol. Interact., 142, 7 (1977)
  • Cruz-Monteagudo, M., et al.: Eur. J. Med. Chem., 40, 1030 (1977)
  • Rothfuss, A., et al.: Chem. Res. Toxicol., 19, 1313 (1977)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle